ARG1 and hyperinsulinemic hypoglycemia, familial, 4: All the mice were ARG1-knockout mice and survived more than 11 weeks without hyperammonemia or body weight loss after continuous treatment of human codon-optimized ARG1 mRNA LNP, which indicates a potential therapeutic strategy for the treatment of arginase deficiency [254].